Tag: TNBC
![](https://owise.uk/wp-content/uploads/sites/2/2024/03/Main-image-1-746x498.jpg)
Keytruda for Secondary Breast Cancer: Science and Stories
Pembrolizumab (Keytruda®) can be used to treat secondary breast cancer. This blog looks at the science and real experience of patients on Keytruda.
![](https://owise.uk/wp-content/uploads/sites/2/2023/10/October-2023-content-3-746x498.jpg)
Trodelvy for Secondary Breast Cancer: Science and Stories
Sacituzumab govitecan (Trodelvy®) is used to treat certain secondary breast cancers. This blog delves into the science while looking at the real experiences of patient’s on this drug.
![Untangling drug terminology](https://owise.uk/wp-content/uploads/sites/2/2021/01/ORNGE-2-746x498.png)
Untangling monoclonal antibodies – Trastuzumab, Pertuzumab, Atezolizumab
We know that drug names can be confusing. That’s why we’re untangling drug terminology. Starting with the monoclonal antibodies (AKA the mabs).
![Two women sitting back to back](https://owise.uk/wp-content/uploads/sites/2/2020/10/back-to-basics-746x498.jpeg)
Triple Negative and Me: TNBC and its treatments
If you have Triple Negative breast cancer, find out exactly what triple negative is and how it can affect your treatment plan.